 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2023 and provided an update on key operational initiatives. The...

LENSAR Reports Second Quarter 2023 Results and Provides Business Update

LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Companys second quarter 2023 financial results will be released before market open on Wednesday...

LENSAR to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023

LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that...

LENSAR Reports Adoption of ALLY System in Multi-Center Ophthalmology Groups

LENSAR (NASDAQ:LNSR Get Free Report) had its target price cut by stock analysts at BTIG Research from $12.00 to $8.00 in a research report issued to clients and investors on Monday, FlyOnTheWall reports. BTIG Researchs price objective points to a potential upside of 119.78% from the stocks current ...

BTIG Research Trims LENSAR (NASDAQ:LNSR) Target Price to $8.00

LENSAR (NASDAQ:LNSR Free Report) and Inspire Medical Systems (NYSE:INSP Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, ...

Contrasting LENSAR (NASDAQ:LNSR) & Inspire Medical Systems (NYSE:INSP)

LENSAR, Inc. (NASDAQ:LNSR Get Rating) Director Aimee S. Weisner purchased 16,647 shares of the companys stock in a transaction dated Monday, May 22nd. The stock was bought at an average cost of $2.75 per share, for a total transaction of $45,779.25. Following the completion of the transaction, the ...

LENSAR, Inc. (NASDAQ:LNSR) Director Aimee S. Weisner Acquires 16,647 Shares of Stock

LENSAR, Inc. (NASDAQ:LNSR  Get Rating) Director Aimee S. Weisner purchased 16,647 shares of the companys stock in a transaction dated Monday, May 22nd. The stock was bought at an average cost of $2.75 per share, for a total transaction of $45,779.25. Following the completion of the ...

LENSAR, Inc. (NASDAQ:LNSR Get Rating) Director Aimee S. Weisner bought 22,153 shares of the stock in a transaction on Friday, May 19th. The stock was purchased at an average price of $2.59 per share, for a total transaction of $57,376.27. Following the completion of the purchase, the director now ...

Aimee S. Weisner Buys 22,153 Shares of LENSAR, Inc. (NASDAQ:LNSR) Stock

LENSAR, Inc. (NASDAQ:LNSR  Get Rating) Director Aimee S. Weisner bought 22,153 shares of the stock in a transaction on Friday, May 19th. The stock was purchased at an average price of $2.59 per share, for a total transaction of $57,376.27. Following the completion of the purchase, the ...

LENSAR (NASDAQ:LNSR Get Rating) issued its quarterly earnings results on Monday. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.13), MarketWatch Earnings reports. LENSAR had a negative net margin of 56.32% and a negative return...

LENSAR (NASDAQ:LNSR) Releases Quarterly  Earnings Results, Misses Estimates By $0.13 EPS

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.

Watchers	87
52-Wk Low	$1.90
52-Wk High	$5.95

Market Cap	$34.86M
Volume (M)	2,374.00
52-Wk High	$5.95
52-Wk Low	$1.90

LNSR LENSAR Inc

About

Feed

News

Earnings

Fundamentals